$PFE News Stock buybacks blamed for lack of U.S.

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2014 at 11:52 AM

$PFE News

Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck

2 Compelling Reasons To Buy Pfizer 10:15 a.m. Today - Seeking Alpha
Australia Targets Multinational Tax Avoidance 5:13 a.m. Today - The Wall Street Journal Interactive Edition
Google, AbbVie in Research Pact 11:32 p.m. Sept. 3, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Targeted U.S. to Fend Off Pfizer 8:24 p.m. Sept. 3, 2014 - The Wall Street Journal Interactive Edition
Triumeq cleared in Europe 9:30 a.m. Sept. 3, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog 6:50 p.m. Sept. 2, 2014 - Zacks.com
AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog 6:40 p.m. Sept. 2, 2014 - Zacks.com
Baxter Will Remain Diversified and With Competitive Advantages 1:49 p.m. Sept. 2, 2014 - GuruFocus.com
Great Biotech Stocks for Retirement Investors 8:47 a.m. Sept. 2, 2014 - InvestorPlace.com
Pfizer: Prescription For A Strong Dividend Yield 11:23 p.m. Sept. 1, 2014 - Seeking Alpha
New Advice for Vaccines to Stave Off Pneumonia 4:55 p.m. Sept. 1, 2014 - The Wall Street Journal Interactive Edition
Retirement Strategy: The Buy The Dips Portfolio Continues To Surge 8:00 a.m. Sept. 1, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - August Update 11:49 p.m. Aug. 29, 2014 - Seeking Alpha
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog 6:10 p.m. Aug. 29, 2014 - Zacks.com
BioMed Realty Inks Lease Agreement with GlycoMimetics in MD - Analyst Blog 5:20 p.m. Aug. 29, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Is GlaxoSmithKline A Solid Long-Term Investment? 1:46 p.m. Aug. 29, 2014 - Seeking Alpha
European Stocks See Tentative Rise 12:37 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
There's No Need for Investors to Fear September 12:18 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com

Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher 9:20 a.m. Today - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. Sept. 3, 2014 - BusinessWire - BZX
BIND Therapeutics Appoints Two New Board Members 8:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Global Diabetic Neuropathy Market 2014-2018 12:48 p.m. Aug. 28, 2014 - PR Newswire - PRF
Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation 8:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard 9:10 a.m. Aug. 27, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 3:23 p.m. Aug. 26, 2014 - PR Newswire - PRF
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen 8:01 a.m. Aug. 26, 2014 - BusinessWire - BZX
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014 2:44 p.m. Aug. 25, 2014 - PR Newswire - PRF
Arteriosclerosis Global Clinical Trials Review, H2, 2014 2:41 p.m. Aug. 25, 2014 - PR Newswire - PRF
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 2:38 p.m. Aug. 25, 2014 - PR Newswire - PRF
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava Facing Securities Fraud Suit; Stocks Down 24%

Endava Hits Rough Patch with Legal Battle Brewing So here we are, watching Endava plc struggle through legal quagmires and tumbling stock prices. Come September 21, 2026, news hit the street: Endava's CFO, Mark Thurston, found himself on administrative leave due to an investigation surrounding some shaky accounting practices. The Audit Committee raised a red flag, and...

JobPlanner Boosts Tools to Shield Margins in Construction

Real-Time Solutions for Real-World Challenges JobPlanner is stepping up its game with some beefed-up financial management tools, and I gotta admit, it's like a lifeline in the raging sea of construction costs. We're talking about a souped-up Real-Time Job Costing Suite tailored for general and specialty contractors who are tired of watching their profits evaporate into...

Chicken Salad Chick Spices Up Holidays With Mary Mistletoe

Dishing Out Holiday Spirit by the Scoop The holiday season's rolling around, and Chicken Salad Chick, this fast-casual joint that's got a bit of a thing for chicken salad, isn't letting the festive season pass by without a splash. They've brought out Mary Mistletoe, a holiday-themed chicken salad offering that just might become your table's centerpiece. "We wanted Mary...

Martin's Holiday Heatwave: Mixing Summer Flavors

Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...

Atrium's Heart Therapies: ATR 1072's Promising Data

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Target Hospitality Readies for Q3 2026 Earnings Reveal

The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...

New Paths Emerge in Thin Film Dewetting Control

The Thin Film Challenge: Decoding Dewetting Ah, dewetting—it's a bit like trying to keep a chocolate bar solid on a scorching summer day. These thin films, they're supposed to hold their own, spread thin and steady. But apply a little heat or a laser, and watch them form tiny islands, like a retreating tide. Now, there's some fresh thinking in the air, straight from...

FirstEnergy Foundation Aims High with New Leadership

Changing the Guard at FirstEnergy Foundation For a company with a hefty footprint across the northeastern United States, FirstEnergy Corp. (NYSE: FE) seems to be diving deep into the philanthropic pool with its recent leadership shuffle. Don Rettig, an experienced figure in the world of corporate philanthropy, is taking the helm as Vice President and President of the...

Ebix and intentyx Tackle AI Security in Regulated Fields

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Harel Insurance Preps Q3 2026 Earnings Report

Harel's Financial Spotlight: Next Moves on November 23, 2026 Harel Insurance Investments, a bigwig in the Israeli insurance landscape, is about to pull back the curtain on its third quarter 2026 financial report. Come November 23, the numbers will hit the streets, and every investor's gotta be asking: what's the latest play from Harel? Exploring Harel's Strategic...